Typbar TCV is a typhoid Vi conjugate vaccine developed by Bharat Biotech for active immunization against typhoid fever caused by Salmonella Typhi. Each 0.5 ml pre-filled syringe contains purified Vi polysaccharide conjugated to a carrier protein to enhance immune response. The conjugate technology ensures stronger and longer-lasting immunity compared to traditional polysaccharide vaccines. Typbar TCV is suitable for infants above 6 months of age, children, and adults, offering broad protection across age groups. It is administered intramuscularly and is particularly beneficial in regions where typhoid is endemic. The vaccine plays a critical role in preventing typhoid-related complications, reducing the need for antibiotics, and controlling the spread of drug-resistant typhoid strains.
Specifications
- Service at Doorstep : FREE Home vaccination availability
- Cold Chain Compliance : Maintains 2-8°C
- VACCINATION KIT : AVAILABLE
- VACCINATION OFFICER : YES